WO2016178490A3 - Composition pharmaceutique pour prévenir ou traiter la goutte et composition alimentaire pour atténuer l'hyperuricémie, contenant un extrait ou une fraction de salvia plebeia r. br. - Google Patents

Composition pharmaceutique pour prévenir ou traiter la goutte et composition alimentaire pour atténuer l'hyperuricémie, contenant un extrait ou une fraction de salvia plebeia r. br. Download PDF

Info

Publication number
WO2016178490A3
WO2016178490A3 PCT/KR2016/004496 KR2016004496W WO2016178490A3 WO 2016178490 A3 WO2016178490 A3 WO 2016178490A3 KR 2016004496 W KR2016004496 W KR 2016004496W WO 2016178490 A3 WO2016178490 A3 WO 2016178490A3
Authority
WO
WIPO (PCT)
Prior art keywords
hyperuricemia
alleviating
fraction
pharmaceutical composition
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2016/004496
Other languages
English (en)
Korean (ko)
Other versions
WO2016178490A2 (fr
Inventor
오좌섭
김진규
최용문
현정미
홍성수
최춘환
서찬곤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyeonggi Institute Of Science & Technology Promotion
Original Assignee
Gyeonggi Institute Of Science & Technology Promotion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyeonggi Institute Of Science & Technology Promotion filed Critical Gyeonggi Institute Of Science & Technology Promotion
Publication of WO2016178490A2 publication Critical patent/WO2016178490A2/fr
Publication of WO2016178490A3 publication Critical patent/WO2016178490A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne une composition pharmaceutique pour traiter la goutte et une composition alimentaire pour atténuer l'hyperuricémie, ces compositions contenant un extrait ou une fraction de Salvia plebeia R. Br. Lesdites compositions présentent une activité inhibitrice de xanthine oxydase, présentant ainsi un effet de traitement ou de prévention de la goutte.
PCT/KR2016/004496 2015-05-04 2016-04-29 Composition pharmaceutique pour prévenir ou traiter la goutte et composition alimentaire pour atténuer l'hyperuricémie, contenant un extrait ou une fraction de salvia plebeia r. br. Ceased WO2016178490A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150062632A KR101702120B1 (ko) 2015-05-04 2015-05-04 곰보배추 추출물 또는 이의 분획물을 포함하는 통풍 예방 또는 치료용 약학적 조성물 및 고요산혈증 개선용 식품 조성물.
KR10-2015-0062632 2015-05-04

Publications (2)

Publication Number Publication Date
WO2016178490A2 WO2016178490A2 (fr) 2016-11-10
WO2016178490A3 true WO2016178490A3 (fr) 2017-01-05

Family

ID=57218249

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/004496 Ceased WO2016178490A2 (fr) 2015-05-04 2016-04-29 Composition pharmaceutique pour prévenir ou traiter la goutte et composition alimentaire pour atténuer l'hyperuricémie, contenant un extrait ou une fraction de salvia plebeia r. br.

Country Status (2)

Country Link
KR (1) KR101702120B1 (fr)
WO (1) WO2016178490A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102070789B1 (ko) * 2019-05-21 2020-01-29 한국 한의학 연구원 곰보배추 추출물 및 이의 분획물을 유효성분으로 포함하는 여드름의 개선 또는 치료용 조성물
CN113694080B (zh) * 2021-08-17 2023-03-28 南京晓庄学院 荔枝草多糖的抗病毒用途
KR102780476B1 (ko) 2024-05-16 2025-03-12 주식회사 상상바이오 요산 배출을 돕고, 과다축적 억제를 통해 요산 수치를 낮춰 통풍 및 통풍성 관절염의 개선에 도움을 주는 식품 조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102861264A (zh) * 2012-10-17 2013-01-09 张群 一种用于治疗痛风的中药组合物
KR20130129868A (ko) * 2012-05-21 2013-11-29 한국생명공학연구원 곰보배추의 추출물 또는 이의 분획물을 유효성분으로 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물
KR101456287B1 (ko) * 2014-03-26 2014-10-31 구례군 배암차즈기 잎을 이용한 항산화 및 항염 기능성차의 제조방법 및 상기 방법을 이용하여 제조한 기능성차

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100527109B1 (ko) 2005-05-19 2005-11-09 학교법인 인제학원 부추 추출물을 함유하는 통풍의 예방 및 치료용 약학조성물
KR101168379B1 (ko) 2010-06-03 2012-07-25 강원대학교산학협력단 가시오갈피 열매 추출물을 포함하는 통풍, 고혈압 및 암의 예방 및 치료용 조성물
KR101332028B1 (ko) * 2012-06-01 2013-11-22 박말녀 곰보배추가 포함된 발효조성물 및 그 제조방법
KR20140106772A (ko) 2013-02-25 2014-09-04 경북대학교 산학협력단 감국(Ｃｈｒｙｓａｎｔｈｅｍｕｍ ｉｎｄｉｃｕｍ Ｌ.) 추출물을 함유하는 통풍억제용 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130129868A (ko) * 2012-05-21 2013-11-29 한국생명공학연구원 곰보배추의 추출물 또는 이의 분획물을 유효성분으로 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물
CN102861264A (zh) * 2012-10-17 2013-01-09 张群 一种用于治疗痛风的中药组合物
KR101456287B1 (ko) * 2014-03-26 2014-10-31 구례군 배암차즈기 잎을 이용한 항산화 및 항염 기능성차의 제조방법 및 상기 방법을 이용하여 제조한 기능성차

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHOI, J. K. ET AL.: "Salvia Plebeia Extract Inhibits the inflammatory Response in Human Rheumatoid Synovial Fibroblasts and a Murine Model of Arthritis", PHYTOMEDICINE, vol. 22, no. 3, 14 February 2015 (2015-02-14), pages 415 - 422, XP029582881 *
JUNG, H. J. ET AL.: "Anti_inflammatory, Anti-angiogenic and Anti-nociceptive Activities of an Ethanol Extract of Salvia Plebeia R. Brown", JOURNAL OF ETHNOPHARMACOLOGY, vol. 126, no. 2, 26 August 2009 (2009-08-26), pages 355 - 360, XP026718082 *

Also Published As

Publication number Publication date
KR20160130624A (ko) 2016-11-14
WO2016178490A2 (fr) 2016-11-10
KR101702120B1 (ko) 2017-02-02

Similar Documents

Publication Publication Date Title
WO2015142001A3 (fr) Composé doté d'une action cardiotonique et composition pharmaceutique permettant de prévenir ou de traiter l'insuffisance cardiaque et contenant ledit composé
PH12018502268A1 (en) Amide-substituted pyridinyltriazole derivatives and uses thereof
HK1247922A1 (zh) 用於治疗癌症的吲哚胺2，3-双加氧酶抑制剂
WO2016172134A3 (fr) Nouveaux composés
WO2017001926A8 (fr) Composés inhibiteurs thérapeutiques
WO2015168466A8 (fr) Inhibiteurs de la déméthylase-1 spécifiques de la lysine
WO2017001936A3 (fr) Composés inhibiteurs thérapeutiques
NZ735044A (en) Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
WO2015200790A3 (fr) Compositions et procédés pour réguler la rénalase dans le traitement de certaines maladies et de certains troubles
EP3207940A4 (fr) Méthodes et compositions de neurégulines permettant de prévenir, traiter ou retarder une insuffisance cardiaque à fraction d'éjection préservée
EP3102220A4 (fr) Compositions de complément alimentaire synergique pour la prévention, le traitement ou la régulation de troubles inflammatoires
IL271807A (en) New compounds and their pharmaceutical preparations for the treatment of leprosy
EP3231436A4 (fr) Composition pharmaceutique pour la prévention ou le traitement d'une maladie métabolique, comprenant des bactéries bacteroides acidifaciens utilisées comme principe actif efficace
HK1210598A1 (en) Di-and tri-heteroaryl derivatives as inhibitors of protein aggregation
EP3103802A4 (fr) Nouveau composé de pyrrolopyrimidine ou sel de celui-ci, composition pharmaceutique le contenant, en particulier agent pour la prévention et/ou le traitement de tumeurs etc. sur la base de l'effet inhibiteur de la nae
EP3279210A4 (fr) Peptide présentant une activité anticancéreuse, et composition pharmaceutique et composition de complément alimentaire pour prévenir et traiter le cancer, le contenant toutes deux en tant qu'ingrédient actif
EP3295946A4 (fr) Composition, contenant un extrait de lithospermi radix en tant que principe actif, pour prévenir, soulager, ou traiter la neuropathie périphérique
EP3501524A4 (fr) Utilisation de la phytosphingosine-1-phosphate ou d'un dérivé de celle-ci en tant qu'activateur immunitaire ou composition pharmaceutique pour le traitement de la démence
WO2016178510A3 (fr) Composition pharmaceutique pour la prévention ou le traitement de la leucémie résistant au gleevec, contenant, comme principe actif, du ginsénoside f1 ou rg3
HK1246679A1 (zh) 丝虫病的治疗
EP3284464A4 (fr) Composition pour la prévention et le traitement de la pancréatite contenant des composés à base de naphthoquinone en tant que principe actif
WO2016048007A8 (fr) Inhibiteur de détection du quorum contenant du d-galactose.
EA033297B1 (ru) Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы
EP3203998A4 (fr) Composés aromatiques substitués et compositions pharmaceutiques pour la prévention et le traitement du diabète
EP3162803A4 (fr) Nouveau composé pour inhiber la liaison entre la protéine dx2 et la protéine p14/arf, et composition pharmaceutique pour le traitement ou la prévention de maladies cancéreuses, comprenant ledit composé en tant que principe actif

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16789596

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 28.03.2018)

122 Ep: pct application non-entry in european phase

Ref document number: 16789596

Country of ref document: EP

Kind code of ref document: A2